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        Asthma is a multifactorial infl  ammatory disor-
der arising as a result of the cellular and mo-
lecular responses induced by allergen exposure 
in sensitized hosts. Allergic asthma is charac-
terized by persistent airway infl  ammation and 
airway hyperresponsiveness (AHR) (  1  ). From 
several clinical and experimental investigations 
(  2  –  5  ), antigen-specifi  c memory T cells, espe-
cially CD4  +   T cells, were shown to play an in-
tegral role in orchestrating the disease process 
through the secretion of a variety of Th2 cyto-
kines, including IL-4, IL-5, and IL-13, which 
induce the development of AHR and eosino-
philic infl  ammation. It has also been reported 
that the transfer of Th2-type cells in mice in-
duces airway eosinophilia and AHR (  6  ). 
  In addition, there is now increasing evi-
dence for the role of CD8  +   T cells in these 
responses as well. Increased numbers of CD8  +   
T cells have been shown in the lungs of asthmatic 
patients (  7  ) and in animal models of allergic 
asthma (  8  ). We demonstrated that allergen-
primed CD8  +   T cells were essential for the full 
development of AHR and airway infl  ammation 
through IL-13 production (  9  ). Subsequently, we 
also reported that in vitro  –  generated allergen-
specifi  c eff  ector memory CD8  +   T (T  EFF  ) cells 
contributed to these responses in the challenge 
phase through their migration into lung tissue 
and local production of IL-13 in sensitized 
and challenged mice (  10  ). We recently demon-
strated the critical role of CD4  +   T cells in the 
sensitization phase for the development of CD8  +   
T cell  –  mediated AHR and airway infl  amma-
tion (  11  ). There are numerous articles addressing 
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  Adoptive transfer of in vivo  –  primed CD8  +   T cells or in vitro  –  generated effector memory 
CD8  +   T (T  EFF  ) cells restores airway hyperresponsiveness (AHR) and airway infl  ammation in 
CD8-defi  cient (CD8    –  /  –   ) mice. Examining transcription levels, there was a strong induction 
of Notch1 in T  EFF   cells compared with central memory CD8  +   T cells. Treatment of T  EFF   cells 
with a     -secretase inhibitor (GSI) strongly inhibited Notch signaling in these cells, and 
after adoptive transfer, GSI-treated T  EFF   cells failed to restore AHR and airway infl  amma-
tion in sensitized and challenged recipient CD8      –  /  –      mice, or to enhance these responses in 
recipient wild-type (WT) mice. These effects of GSI were also associated with increased 
expression of the Notch ligand Delta1 in T  EFF   cells. Treatment of sensitized and challenged 
WT mice with Delta1-Fc resulted in decreased AHR and airway infl  ammation accompanied 
by higher levels of interferon      in bronchoalveolar lavage fl  uid. These results demonstrate a 
role for Notch in skewing the T cell response from a T helper (Th)2 to a Th1 phenotype as 
a consequence of the inhibition of Notch receptor activation and the up-regulation of the 
Notch ligand Delta1. These data are the fi  rst to show a functional role for Notch in the 
challenge phase of CD8  +   T cell  –  mediated development of AHR and airway infl  ammation, 
and identify Delta1 as an important regulator of allergic airway infl  ammation. 1088 NOTCH ON CD8  +  T CELLS REGULATES AIRWAY FUNCTION | Okamoto et al.
the surface after stimulation and is down-regulated by 72 h (  28  ). 
To eff  ectively maintain GSI interference in transferred cells, 
we used a secondary challenge protocol in which the analysis 
of AHR was completed within 48 h of a single provocative 
secondary allergen challenge (  27  ) and transfer of GSI-transferred 
CD8  +   T  EFF   cells. 
  Notch1 signaling is activated in T  EFF   cells after engagement 
of the TCR 
  To confi  rm Notch1 signaling in CD8  +   T  EFF   cells, we exam-
ined Notch1 protein cleavage. Engagement of Notch by any 
of its ligands results in proteolytic cleavage at an intracellular 
site between glycine 1743 and valine 1744. This cleavage 
event, which results in the liberation of NICD, is dependent 
on the enzymatic activity of the     -secretase complex that con-
tains presenilins and nicastrin (  29, 30  ). CD8  +   T  EFF   cells isolated 
from the lymph nodes or spleens of OT-1 mice were stimu-
lated with anti-CD3 plus anti-CD28 or SIINFEKL peptide 
in the presence of DMSO (vehicle) or 20   μ  M GSI for 24 h. 
The cell lysates were analyzed by Western blotting for the 
the molecules that regulate eff  ector functions or activation of 
CD8  +   T cells (  12, 13  ). 
  The Notch signaling pathway plays a fundamental role in 
cell fate decisions in all organisms (  14  ). In mammals, there are 
four identifi  ed Notch receptors (Notch1  –  4) and fi  ve ligands 
of the Delta-like families (Delta1, Delta3, and Delta4) and 
Jagged families (Jagged1 and Jagged2) (  14  ). Notch receptors 
and their ligands are also expressed on the surface of mature 
lymphocytes and APCs. Notch proteins are transcriptional 
  activators expressed fi  rst as transmembrane heterodimeric surface 
receptors. After ligation, Notch undergoes proteolytic pro-
cessing, including a fi  nal cleavage by     -secretase to release the 
Notch intracellular domain (NICD), which translocates to the 
nucleus and binds to CSL/RBP-J transcription factor, con-
verting it from a repressor to an activator of gene transcription 
(  14  –  16  ). Several target genes of Notch, including Hes1, Hes5, 
and pT have been identifi  ed (  17, 18  ).     -secretase inhibitors 
(GSIs) can eff  ectively prevent the enzymatic cleavage of the 
cytoplasmic domain of Notch receptors, thereby inhibiting 
the downstream signaling events triggered by activation of 
these receptors (  19  ). 
  Recently, studies have implicated Notch in activation (  20  –
  23  ) and diff  erentiation (  24  –  26  ) of cells of the peripheral im-
mune system. The role of Notch signaling, especially in CD8  +   
T  EFF   cells, and its involvement in allergen-induced AHR and 
airway infl  ammation have not been defi  ned. In this study, we 
demonstrated Notch1 expression on CD8  +   T  EFF   cells and that 
inhibition of Notch signaling using GSI reversed their eff  ects 
on development of AHR and airway infl  ammation, in part 
due to the up-regulation of IFN-     production. Further, we 
showed that Delta1, a Notch ligand, is an eff  ective inhibitor of 
allergen-induced AHR. 
    RESULTS   
  Notch1 is expressed in T  EFF   cells but not central memory 
CD8  +   T (T  CM  ) cells 
  We previously showed that the development of AHR and 
eosinophilic infl  ammation in CD8      /      mice was lower than in 
WT mice but could be fully restored after transfer of CD8  +   T 
cells from antigen-primed donors or after transfer of in vitro  –
  generated CD8  +   T  EFF   cells but not CD8  +   T  CM   cells (  10  ). 
Reconstitution of heightened airway responsiveness by T  EFF   
cells was paralleled by restoration of bronchoalveolar lavage 
(BAL) and tissue eosinophilia, BAL IL-13 levels, and goblet 
cell metaplasia. To determine if there were diff  erences in gene 
expression between T  EFF   and T  CM   cells, microarray analysis was 
performed (the microarray data have been deposited in the 
GEO database under accession number GSM8632). In the 
analysis of T  EFF   and T  CM   cell total RNA, an up-regulation of 
Notch1 was detected in T  EFF   cells, which was   >  1,000-fold 
higher than in T  CM   cells (P   <   0.05) (  Fig. 1 A  ).   In contrast, the 
expression of Notch2 and Notch3 was only minimally higher 
in T  EFF   cells. 
  Because Notch is not up-regulated and NICD is not de-
tected until T  EFF   cells are activated through the antigen recep-
tor (or TCR) (  Fig. 1 B  ), Notch1 expression is not retained on 
    Figure 1.         Notch receptor expression and signaling in CD8    +     T  EFF   
cells.   (A) Relative gene expression of Notch family members in T  EFF   versus 
T  CM   cells. The expression of Notch on T  EFF   and  T CM   cells was determined by 
gene chip analysis. The relative gene expression difference for the hybrid-
ization signal is depicted as a ratio. #, P   <   0.05 summarizing the results of 
three separate experiments performed in duplicate. (B) Notch signaling is 
activated in T  EFF   cells.  T EFF   cells were stimulated with anti-CD3 and anti-
CD28 or SIINFEKL for 24 h after incubation of the cells with DMSO or GSI. 
Cell lysates were analyzed for the expression of Notch1 by Western blot-
ting, and     -  actin was used as a loading control. One representative of 
three similar experiments is shown.     JEM VOL. 205, May 12, 2008 
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  Cytokine levels in BAL fl  uid of WT mice after transfer 
of GSI-T  EFF   cells or DMSO-T  EFF   cells 
  The relative levels of Th1 and Th2 cytokines have been pro-
posed to play an important role in the development of allergic 
airway infl  ammation (  33  ). After transfer of T  EFF   cells pretreated 
with DMSO into secondary challenged WT mice, IL-4 and 
IL-13 levels in BAL of recipients of DMSO-T  EFF   cells were 
increased, whereas GSI-T  EFF   cell recipients showed smaller in-
creases in IL-4 and IL-13 but markedly increased levels of IFN-    
(  Fig. 2 D  ). Similar results on cytokine production were observed 
when lung cells were assayed (Fig. S2, available at http://www
.jem.org/cgi/content/full/jem.20072200/DC1). 
  The expression of T-bet and GATA-3 in homogenized lung 
  Because the balance between the transcription factors T-bet 
and GATA-3 has been associated with the predominance of 
Th1 and Th2 responses, respectively (  12  ), we analyzed levels 
of these transcription factors using real-time PCR in homog-
enized lung samples from mice that received GSI-T  EFF   cells 
or DMSO-T  EFF   cells. In parallel to the results of BAL cyto-
kine levels, the expression level of T-bet in recipients of GSI-
T  EFF   cells was signifi  cantly higher than in the other groups; 
the expression level of GATA-3 in GSI-T  EFF   cell recipients 
was signifi  cantly decreased (  Fig. 2 E  ). 
  IFN-     production in CD4  +   or CD8  +   T cells 
  To identify the source of IFN-     production in the recipients of 
GSI-T  EFF   cells, mononuclear cells (MNCs) were obtained from 
the lung tissue of recipient WT mice after transfer of either 
GSI-T  EFF   cells or DMSO-T  EFF   cells 48 h after secondary OVA 
challenge. As shown in   Table I  , the number of IFN-      +   cells in 
the CD4  +   fraction of GSI-T  EFF   cell recipients was signifi  cantly 
higher than in the DMSO-T  EFF   cell recipients.   However, the 
number of IFN-      –  producing lung CD8  +   T cells was signifi  -
cantly decreased in GSI-T  EFF   cell recipients compared with 
DMSO-T  EFF   cell recipients (  Table I  ). 
  Effects of GSI-T  EFF   cell transfer on allergen-induced AHR 
and airway infl  ammation in CD8    –  /  –    recipients 
  T  EFF   cells transferred into primary challenged CD8      /      mice 
restored the full development of AHR and airway infl  am-
mation (  10  ). To analyze the role of Notch signaling in the 
cleaved form of Notch1 using a cleavage-specifi  c antibody 
(  Fig. 1 B  ). Cleaved Notch1 was detected in T  EFF   cells cultured 
with either anti-CD3 plus anti-CD28 or SIINFEKL. Treatment 
with GSI dramatically reduced the levels of cleaved Notch1 
protein after TCR or antigen-specifi  c activation. Examination 
of cell proliferation and cell survival showed no eff  ect of GSI 
treatment on these parameters (unpublished data). These data 
demonstrate that Notch1 signaling can be inhibited pharmaco-
logically in CD8  +   T  EFF   cells activated through the TCR. 
  Effects of transfer of GSI-T  EFF   cells on allergen-induced 
AHR and airway infl  ammation in WT mice 
  To assess the eff  ects of the Notch signaling pathway on the 
enhancement of the functional activity of CD8  +   T  EFF   cells 
in vivo, GSI-T  EFF   cells or DMSO-T  EFF   cells were transferred 
into sensitized and challenged recipient WT mice before 
secondary OVA challenge. Secondary challenge of sensitized 
and challenged mice led to the development of increased 
AHR in WT mice, illustrated by signifi  cant increases in lung 
resistance (RL) (  Fig. 2 A  ), as described previously in this 
model (  31  ).     Fig. 2 A   also illustrates the changes in RL in WT 
recipients of GSI-T  EFF   cells or DMSO-T  EFF   cells undergoing 
secondary challenge. AHR to methacholine (MCh) was sig-
nifi  cantly increased in recipients of DMSO-T  EFF   cells, but 
recipients of GSI-T  EFF   cells failed to increase AHR over that 
seen in WT mice not receiving T  EFF   cells. Indeed, transfer 
of DMSO-T  EFF   cells signifi  cantly increased AHR, whereas 
transfer of GSI-T  EFF   cells inhibited the response to a modest 
degree. In parallel to the assessment of lung function, the 
  infl  ammatory cell composition of BAL fl  uid was examined 
(  Fig. 2 B  ). Eosinophil numbers in BAL fl  uid were signifi  -
cantly increased in the DMSO-T  EFF   cell recipient mice, 
whereas GSI-T  EFF   cell recipient mice did not show such in-
creases. In contrast, neutrophil numbers were increased in 
GSI-T  EFF   cell recipients. Transfer of either DMSO-T  EFF   cells 
or GSF T  EFF   cells increased lymphocyte numbers in BAL 
fl  uid compared with WT control mice after secondary aller-
gen challenge. 
  Cell composition of BAL fl  uid was examined in WT re-
cipients of GSI-T  EFF   cells or DMSO-T  EFF   cells by fl  ow cy-
tometry 48 h after the secondary challenge. Previous studies 
demonstrated that adoptively transferred T  EFF   cells preferen-
tially migrated into allergen-challenged airways via BLT1 (  32  ). 
The numbers of CD8  +   T cells in the BAL fl  uid were increased 
to a similar extent in recipients of either DMSO-T  EFF   cells 
or GSI-T  EFF   cells compared with secondary challenged WT 
control mice (  Fig. 2 C  ). In addition, the percentages of CD8  +   
T cells among total BAL cells were higher in both recipi-
ents of DMSO-T  EFF   cells (20.4   ±   1.7%) and GSI-T  EFF   cells 
(19.4   ±   1.3%) than in secondary challenged WT control mice 
(6.6   ±   0.4%). These data demonstrate that the accumulation of 
CD8  +   T cells in the airways after T  EFF   cell transfer and second-
ary allergen challenge was not altered by pretreatment with 
GSI. The results from lung cell digestion were similar to those 
observed in BAL fl  uid (Fig. S1, available at http://www.jem
.org/cgi/content/full/jem.20072200/DC1). 
  Table I.      Number of IFN-    +   CD3 + CD4 +   or IFN-    +   CD3 + CD8 +  
cells in the lungs of sensitized and challenged WT mice that 
received DMSO-T  EFF   or GSI-T  EFF   cells 
  CD4  +  IFN-      +   (  ×  10  4  )   CD8  +  IFN-      +   (  ×  10  4  ) 
WT 28.8   ±   1.9 13.2   ±   1.9
DMSO-T  EFF 40.8    ±   4.8 32.3   ±   3.0
GSI-T  EFF 69.7    ±   5.5    a   25.3    ±   3.2    b   
Mean values   ±   SEM are given. WT, OVA-sensitized and challenged WT mice; DMSO-T  EFF , 
DMSO-treated T  EFF  cell recipient WT mice that were OVA sensitized and challenged; GSI-T  EFF , 
GSI-treated T  EFF   cell recipient WT mice that were OVA sensitized and challenged.
  a  P   <   0.05  compared  between  GSI-T EFF   cells versus WT and DMSO-T  EFF   cells.
  b  P   <   0.05  compared  between  GSI-T EFF   cells versus DMSO-T  EFF   cells.1090 NOTCH ON CD8  +  T CELLS REGULATES AIRWAY FUNCTION | Okamoto et al.
reconstituted the development of AHR and eosinophilic 
airway infl  ammation. The development of AHR in CD8      /      
recipients of DMSO-T  EFF   cells was not signifi  cantly diff  erent 
from WT recipients of DMSO-T  EFF   cells. Transfer of GSI-
T  EFF   cells into CD8      /      failed to increase AHR or airway 
eosinophilia, but it did increase the numbers of neutrophils 
reconstitution of CD8      /      mice after secondary allergen 
challenge, GSI-T  EFF   cells or DMSO-T  EFF   cells were trans-
ferred into sensitized and challenged CD8      /      mice before 
secondary allergen challenge. As shown in   Fig. 3   (A and B), 
CD8      /      mice developed signifi  cantly lower responses after 
secondary allergen challenge.   Transfer of DMSO-T  EFF   cells 
    Figure 2.         Transfer of GSI-T  EFF   cells fails to enhance lung allergic responses in WT recipients.   Sensitized and challenged WT mice received GSI-
T  EFF   or DMSO-T  EFF   cells before secondary challenge (OVA/OVA/OVA). Control mice were those that were sensitized and challenged but received PBS at the 
time of secondary challenge (OVA/OVA/PBS). (A) RL values were obtained in response to increasing concentrations of inhaled MCh, as described in Mate-
rials and methods. Data represent the mean   ±   SEM (  n   = 12 in each group). #, signifi  cant difference (P   <   0.05) between DMSO-T  EFF   cell recipients and WT 
control mice or GSI-T  EFF   cell recipients. (B) Cellular composition of BAL fl  uid. #, signifi  cant difference (P   <   0.05) between GSI-T  EFF   cell recipients and 
DMSO-T  EFF   cell recipients;   ‡  , signifi  cant difference (P   <   0.05) between DMSO-T  EFF   cell recipients and WT control mice; *, signifi  cant difference (P   <   0.05) 
between GSI-T  EFF   cell recipients and WT mice. (C) CD4  +   and  CD8 +   T cells in BAL fl   uid.   ‡ ,  signifi  cant difference (P   <   0.05) between DMSO-T  EFF   cell  recipients 
and WT control mice; *, signifi  cant difference (P   <   0.05) between GSI-T  EFF   cell recipients and WT mice. (D) Cytokine levels in BAL fl  uid of WT mice that 
received GSI-T  EFF   or  DMSO-T EFF   cells. #, signifi  cant difference (P   <   0.05) between GSI-T  EFF   cell recipients and DMSO-T  EFF   cell  recipients;   ‡ ,  signifi  cant differ-
ence (P   <   0.05) between DMSO-T  EFF   cell recipients and WT control mice; *, signifi  cant difference (P   <   0.05) between GSI-T  EFF   cell recipients and WT control 
mice. (E) Relative expression levels of GATA-3 and T-bet in the lung were determined by quantitative real-time PCR. Lung cells are from the same groups 
as described in A. They were isolated using collagenase digestion, and RNA was prepared. Results are representative of three independent experiments. 
The results for each group are expressed as mean   ±   SEM. #, signifi  cant difference (P   <   0.05) between GSI-T  EFF   cell – transferred  mice  and  DMSO-T EFF   cell –
  transferred mice or WT control mice.     JEM VOL. 205, May 12, 2008 
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from the lungs of secondary challenged CD8      /      recipients of 
either GSI-T  EFF   cells or DMSO-T  EFF   cells and analyzed by 
real-time PCR. T cells are reported to express the Notch lig-
ands Delta1 (  34  ), Jagged1 (  35  ), and Jagged2 (  36  ). In parallel to 
the data on BAL (and lung cell) cytokine production and the 
induction of T-bet expression in the lung, we showed that 
the level of Delta1 expression was higher in isolated GSI-T  EFF   
cells compared with isolated DMSO-T  EFF   cells (  Fig. 4  ).   Base-
line levels of Delta1 expression in either GSI-T  EFF   cells or 
DMSO-T  EFF   cells before transfer were extremely low in the 
absence of activation. There were no signifi  cant diff  erences in 
the levels of expression of the other Notch ligands (Jagged1 
and Jagged2). 
  Effects of administration of Delta1-Fc to WT mice 
on allergen-induced AHR and airway infl  ammation 
  To directly test whether Delta1 regulates AHR and airway in-
fl  ammation, sensitized and challenged WT mice were treated 
with Delta1-Fc or human IgG as a control before secondary 
OVA challenge (OVA/OVA/OVA) (  Fig. 5 A  ).   Administration 
in BAL fl  uid. IFN-     levels in BAL fl  uid were also increased in 
GSI-T  EFF   cell recipients compared with recipients of DMSO-
T  EFF   cells, whereas the opposite was true for IL-4 and IL-13 
(  Fig. 3 C  ). 
  MNCs were obtained from the lung tissue of recipient 
CD8    –  /  –    mice after the transfer of either GSI-T  EFF   cells or 
DMSO-T  EFF   cells 48 h after secondary challenge and assessed 
by fl  ow cytometry (  Table II  ).   The number of CD4  +  IFN-      +   
T cells in GSI-T  EFF   cell recipients was signifi  cantly higher than 
in the DMSO-T  EFF   cell recipients. However, the number of 
IFN-      –  producing lung CD8  +   T cells was lower in GSI-T  EFF   
cell recipients than in DMSO-T  EFF   cell recipients. Based on 
these results, it appeared that the source of increased IFN-     
production and Th1 polarization was lung CD4  +   T cells in the 
recipients of GSI-T  EFF   cells. 
  Expression of Delta1 in T  EFF   cells from CD8      /      recipients 
of GSI-T  EFF   cells or DMSO-T  EFF   cells 
  To determine if Notch ligand expression was involved in the 
response of the transferred cells, CD8  +   T  EFF   cells were isolated 
    Figure 3.         Allergen-induced AHR and airway infl  ammation are restored in CD8      /      mice that received DMSO-T  EFF   cells but not GSI-T  EFF   cells.  
Before secondary challenge, sensitized and challenged (primary) CD8     /     mice received 5   ×   10  6   GSI-T EFF   or  DMSO-T EFF   cells via the tail vein. Control mice 
were sensitized and challenged and received PBS on secondary challenge. (A) AHR. #, signifi  cant difference (P   <   0.05) between DMSO-T  EFF   cell recipients and 
controls or GSI-T  EFF   cell recipients. (B) Cell composition in BAL fl  uid and (C) BAL cytokine levels. The results for each group are expressed as the mean   ±   
SEM (  n   = 12). #, signifi  cant difference (P   <   0.05) between GSI-T  EFF   cell recipients and DMSO-T  EFF   cell recipients;   ‡  , signifi  cant difference (P   <   0.05) between 
DMSO-T  EFF   cell recipients and controls; *, signifi  cant difference (P   <   0.05) between GSI-T  EFF   cell recipients and controls.     1092 NOTCH ON CD8  +  T CELLS REGULATES AIRWAY FUNCTION | Okamoto et al.
these groups. The results in BAL fl  uid were confi  rmed using lung 
cells (Fig. S3, available at http://www.jem.org/cgi/content/
full/jem.20072200/DC1). 
    DISCUSSION   
  The Notch signaling pathway is a highly conserved program 
for cell fate decisions in all organisms, infl  uencing apoptosis or 
cell cycle arrest (  37, 38  ). The signal induced by ligand binding 
is conveyed intracellularly by a process involving proteolytic 
cleavage of the receptor and nuclear translocation of the in-
tracellular domain of the Notch family protein. The GSIs 
prevent the generation of the NICD and suppress Notch ac-
tivity. In the immune system, several studies have implicated 
Notch signaling in hematopoiesis, T  –  B lineage commitment, 
and thymic T cell development (  16, 39  –  41  ). Notch gene ex-
pression is induced and Notch1 is activated after CD4  +   T cell 
activation, possibly through a   “  positive feedback loop  ”   in ad-
jacent cells (  21  ). Studies have also suggested that Notch may 
infl  uence both Th1 and Th2 polarization (  25, 26  ). 
  In contrast to several reports that analyzed the relationship 
between CD4  +   T cells and Notch in the peripheral immune sys-
tem, there is a paucity of information regarding a role for Notch 
signaling in CD8  +   T cells. Several studies have suggested that the 
activation of Notch suppresses CD8  +   T cell eff  ector functions 
(  23, 42  ). On the other hand, Palaga et al. (  20  ) reported that the 
number of IFN-      –  producing CD8  +   T cells was signifi  cantly re-
duced by inhibition of Notch signaling, indicating that the acti-
vation of Notch may be required for CD8  +   T cell function. 
  There is now increasing evidence that in addition to CD4  +   
T cells, CD8  +   T cells contribute to the development of allergic 
disease (  7  –  10, 43  –  45  ). In the development of CD8  +   T cell  –
  mediated AHR and eosinophilic infl  ammation, CD4  +   T cells 
play an essential role in the sensitization phase (  11  ). We previ-
ously showed that CD8    –  /  –    mice develop lower levels of AHR 
and eosinophilic infl  ammation compared with WT mice, and 
these responses can be restored by transfer of in vivo  –  activated 
CD8  +   T cells from antigen-primed donors or by transfer of in 
vitro  –  generated CD8  +   T  EFF   cells, but not CD8  +   T  CM   cells, be-
fore challenge (  9, 10  ). Recently, we showed that T  EFF   cells up-
regulate BLT1 (  32  ), the high affi   nity receptor for LTB4 (  46  ), 
and BLT1 plays a critical role in the recruitment of T  EFF   cells 
into allergen-challenged lungs resulting in AHR and airway 
infl  ammation (  32  ). 
  In this study, we used transcript expression profi  le analysis 
to defi  ne gene diff  erences between T  EFF   and T  CM   cells. In light 
of the fi  ndings that Notch1 expression was much higher in 
CD8  +   T  EFF   than T  CM   cells, we investigated the role of this 
signaling molecule in CD8-mediated allergic airway responses. 
We fi  rst demonstrated that Notch can signal T  EFF   cells and 
determined the role of this signaling pathway using a phar-
macological approach. We showed that after incubation of 
CD8  +   T  EFF   cells with anti-CD3/anti-CD28 or the addition 
of SIINFEKL, cleaved Notch1 could be detected confi  rming 
Notch signaling, and incubation of T  EFF   cells with the GSI 
prevented this cleavage in vitro. 
of Delta1-Fc markedly reduced AHR compared with adminis-
tration of (control) human IgG in response to secondary aller-
gen challenge (  Fig. 5 B  ). Neither Delta1-Fc nor human IgG 
altered the response in control mice (OVA/OVA/PBS). In par-
allel, administration of Delta1-Fc to secondary challenged mice 
markedly reduced the numbers of eosinophils and levels of IL-
13 in the BAL fl  uid without aff  ecting these responses in con-
trols (  Fig. 5, C and D  ). 
  Administration of Delta1-Fc to secondary challenged 
mice resulted in signifi  cantly increased levels of IFN-     in the 
BAL fl  uid. To confi  rm these eff  ects of Delta1-Fc and IFN-     
production, MNCs were obtained from the lung tissue of 
secondary challenged mice or control mice. As shown in   
Fig. 5 E  , the number of CD4  +  IFN-      +   T cells in mice treated 
with Delta1-Fc was signifi  cantly higher than in those that 
received human IgG (or controls that received Delta1-Fc or 
human IgG). However, the number of CD8  +  IFN-      +   lung 
CD8  +   T cells was not significantly different among any of 
  Table II.      Number of IFN-    +   CD3 + CD4 +   or IFN-    +   CD3 + CD8 +  
cells in the lungs of sensitized and challenged CD8     /     mice 
that received DMSO-T  EFF   or GSI-T  EFF   cells 
  CD4  +  IFN-      +   (  ×  10  4  )   CD8  +  IFN-      +   (  ×  10  4  ) 
CD8-defi  cient 18.0   ±   1.2   — 
DMSO-T  EFF 35.0    ±   5.6 21.6   ±   4.2
GSI-T  EFF 50.7    ±   3.8    a   14.3    ±   1.3    b   
Mean values   ±   SEM are given. CD8-defi  cient, OVA-sensitized and challenged CD8-
defi  cient mice; DMSO-T  EFF  , DMSO-treated T  EFF   cell recipient CD8-defi  cient mice that 
were OVA sensitized and challenged; GSI-T  EFF  , GSI-treated T  EFF   cell recipient CD8-
defi  cient mice that were OVA sensitized and challenged.
  a    P   <   0.05 compared between GSI-T  EFF   cells versus CD8-defi  cient and 
DMSO-T  EFF   cells.
  b    P   <   0.05 compared between GSI-T  EFF   cells versus DMSO-T  EFF   cells.
    Figure 4.         Real-time PCR analysis of Notch ligand expression in 
T  EFF   cells.   Before and after transfer of GSI-T  EFF   or  DMSO-T EFF   cells,  CD8 +  
T  EFF   cells from the lungs of CD8   – / –    mice were isolated using MACS beads 
and RNA was prepared. The relative expression of Notch ligands (Delta1, 
Jagged1, and Jagged2) was determined by quantitative real-time PCR. 
Results are from three independent experiments. The results for each 
group are expressed as mean   ±   SEM. #, signifi  cant difference (P   <   0.05) 
between GSI-T  EFF   cell recipients and DMSO-T  EFF   cell  recipients.   JEM VOL. 205, May 12, 2008 
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intranasal administration of IFN-     eff  ectively inhibited gob-
let cell metaplasia (  49  ). Additionally, IFN-     has been shown 
to inhibit airway smooth muscle contraction (  50  ) and prolif-
eration (  51  ). 
  Diff  erentiation of Th1 and Th2 cells is tightly cross-
regulated so that development of one subset is inhibited by 
cytokines produced by the other (  52  ). T-box expressed in 
T cells (T-bet) plays a central role in Th1 development by 
activating Th1 genetic programs, IFN-     production, and re-
pressing Th2 cytokine synthesis (  52  ). In contrast, GATA-3 
serves as a Th2 cytokine-specifi  c transcription factor selec-
tively expressed in Th2 cells (  53, 54  ) and leads to inhibition 
of IFN-     production (  55  ). In the secondary challenge model, 
transfer of GSI-treated T  EFF   cells shifted the balance with 
modest increases and decreases in T-bet and GATA-3, re-
spectively, accompanied by failure to enhance lung allergic 
responses. However, the balance was not shifted to the ex-
tent that the transfer of GSI-treated T  EFF   cells prevented sen-
sitized and challenged host cells from contributing to the lung 
allergic responses. 
  These observations were extended to assess the eff  ects of 
preventing Notch cleavage in vivo. To eff  ectively maintain 
GSI interference, we used a secondary challenge protocol in 
which the analysis of AHR was completed within 48 h of 
transfer of GSI-treated CD8  +   T  EFF   cells (  27  ). In sensitized 
and challenged WT recipients, secondary challenge elicited 
AHR and airway infl  ammation. Transfer of DMSO (control)-
treated T  EFF   cells led to further increases in AHR, airway eo-
sinophilia, and BAL IL-4 and IL-13 levels. In contrast, transfer 
of GSI-treated T  EFF   cells failed to enhance the responses over 
those seen in WT mice. Notably, levels of BAL IFN-     were 
markedly increased in these recipients as were the levels of 
expression of T-bet with a decrease in GATA-3 expression. 
These results were not attributable to diff  erences in the abil-
ity of GSI-T  EFF   cells to accumulate in the lung, as the num-
bers of GSI- and DMSO-treated cells in the lung were the 
same. The failure of GSI-T  EFF   cells to enhance AHR or eo-
sinophilic airway infl  ammation could be attributed to the in-
creases in IFN-     production. We previously demonstrated 
that IFN-     has the potential to inhibit AHR (  47, 48  ) and that 
    Figure 5.         Allergen-induced AHR and airway infl  ammation are prevented by administration of Delta1-Fc.   Secondary challenged (OVA/OVA/OVA) 
or control (OVA/OVA/PBS) WT mice received Delta1-Fc or human IgG. (A) Experimental protocol, (B) AHR, (C) cell composition in BAL fl  uid, (D) BAL cyto-
kine levels, and (E) number of IFN-    +  – producing  CD4 +   or  CD8 +   T cells in the lung. The results for each group are expressed as the mean   ±   SEM (  n   = 8 in 
each group). #, signifi  cant difference (P   <   0.05) between Delta1-Fc  –  treated secondary challenged mice and human IgG  –  treated secondary challenged 
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ciated with increased numbers of CD4  +  IFN-      +   T cells in sec-
ondary challenged mice. These data are consistent with reports 
that Delta1 interacts with CD4  +   T cells and enhances IFN-     
production in antigen-stimulated CD4  +   T cells (  25, 26  ). 
  To further extend these observations, we examined the 
consequences of administering a Delta1-Fc protein before 
secondary challenge. Administration of Delta1-Fc resulted in 
increased IFN-     production from CD4  +   T cells, and this was 
associated with a signifi  cant inhibition of the development 
of AHR, airway eosinophilia, and BAL IL-13 levels. At the 
same time, BAL IFN-     levels were increased. These results are 
similar to recent observations in experimental autoimmune 
encephalomyelitis, where treatment with Delta1-Fc increased 
the number of Th1 cells in the central nervous system (  58  ). 
Control mice that received Delta1-Fc did not increase the 
number of IFN-      –  producing lung CD4  +   T cells, suggesting 
that in the absence of activation, the expression of Notch is 
not up-regulated and that interactions between Notch recep-
tor and Delta1-Fc do not take place. In recipients of Delta1-
Fc, we detected the highest numbers of CD4  +  IFN-      +   T cells 
and levels of IFN-    , accompanied by markedly reduced levels 
of IL-4 and IL-13 in secondary challenged mice (Fig. S3). 
  After adoptive transfer, CD8  +   T  EFF   cells in the lung ex-
hibit a Th2 phenotype (  10, 32  ). Thus, the phenotype of pre-
dominant Th1-type cytokine-producing CD8  +   T cells could 
be redirected toward Th2-type cytokine production in the 
lungs of sensitized and challenged mice, a plasticity previously 
emphasized in CD4  +   T cells (  59  ). As a result of the inhibition 
of Notch signaling by GSI, Th2 cytokine production by these 
lung CD8  +   T  EFF   cells was superseded by Notch receptor  –
  Notch ligand interactions and increased IFN-     production in 
CD4  +   T cells. Collectively, these data identify a new pathway 
involved in the regulation of CD4  +    –  CD8  +   T cell interactions 
and the development of Th2-mediated allergic responses 
through Notch signaling. The pathway appears tightly regu-
lated by the expression pattern of Notch receptor and the 
Delta1 Notch ligand, which are in turn dependent on the ac-
tivation of T cells. The data reveal the therapeutic potential of 
Delta1-Fc in the regulation of allergen-induced AHR. 
  MATERIALS AND METHODS 
  Mice.     WT C57BL/6 and OT-1 mice (C57BL/6 strain) expressing a transgenic 
TCR that is specifi  c for OVA  257  –  264   (SIINFEKL) peptide (  60  ) were purchased 
from The Jackson Laboratory. Homozygous CD8-defi  cient (CD8      /     ) mice, 
generated by targeting the   CD8       chain gene in C57BL/6 mice (  61  ), were ob-
tained from P. Marrack (National Jewish Medical and Research Center, Den-
ver, CO). Each experiment was independently performed at least three times 
with four mice/group (  n   = 12). Controls were matched with the defi  cient mice 
with regard to both age and gender in each experimental group. All studies 
were conducted under a protocol approved by the Institutional Animal Care 
and Use Committee of the National Jewish Medical and Research Center. 
  Cell (CD8 T cell) preparation and culture.     Diff  erentiation of T  EFF   and 
T  CM   cells in vitro was performed as described previously (  62, 63  ). For pro-
liferation assays, T  EFF   cells on day 6 were cultured with GSI or DMSO and 
IL-2 for 24 h, followed by cell count analysis (Coulter Counter). For the 
protein and RNA assays, isolated T  EFF   cells were stimulated with 2   μ  g/ml of 
plate-bound anti-CD3 plus 2   μ  g/ml anti-CD28 (R  &  D Systems) or 1   μ  g/ml 
SIINFEKL peptide in the presence of DMSO (0.1% fi  nal concentration) or 
  A similar pattern was seen in CD8      /      recipients where 
transfer of GSI-treated T  EFF   cells, unlike DMSO-treated T  EFF   
cells, failed to reconstitute AHR, airway eosinophilia, or BAL 
IL-13 levels. As in WT recipients, transfer of GSI-treated 
T  EFF   cells resulted in increased IFN-     levels in BAL. In vitro, 
incubation of GSI-treated T  EFF   cells with anti-CD3/anti-
CD28 or SIINFEKL did lead to decreased expression of 
Notch1 mRNA (unpublished data), in keeping with the re-
duced levels of Notch1 cleavage protein determined by West-
ern blotting. In parallel, activation through the TCR of the 
GSI-treated T  EFF   cells led to increases in the expression of 
Delta1 mRNA. However, these changes were only seen when 
GSI-T  EFF   cells were co-cultured with CD8  +   T  EFF   cells during 
the activation period, but not when the GSI-T  EFF   cells were 
cultured alone (Fig. S4, available at http://www.jem.org/
cgi/content/full/jem.20072200/DC1). After GSI-T  EFF   cell 
transfer and recovery from the lungs of secondary challenged 
CD8      /      mice, we noted a marked up-regulation of Delta1 
mRNA compared with recovered DMSO-treated T  EFF   cells, 
with little or no diff  erence between the two in levels of Jag-
ged1 or Jagged2 mRNA. 
  Notch  –  Notch ligand interactions govern cell fate deci-
sions in T cells. Notch signaling can direct Th2 diff  erentia-
tion via GATA-3 (  56, 57  ). In vertebrates, Notch can bind to 
two diff  erent families of ligands, Delta-like (  34  ) and Jagged1 
and Jagged2 (  35, 36  ). Stimulation of naive CD4  +   T cells 
with Delta1 involving interactions with Notch3 promotes 
the diff  erentiation toward the Th1 pathway (  25  ), whereas 
Jagged1-mediated Notch1 activation is critical in driving Th2 
diff  erentiation (  26  ). As a rule, the ligands tend to be expressed 
in a more highly restricted pattern than their receptors. 
  These eff  ects of GSI on CD8  +   T  EFF   cells decreasing Notch1 
expression, reducing Notch1 cleavage, and increasing T-bet 
and Delta1 expression, and the associated inhibition of en-
hancement or failure to restore lung allergic responses together 
with increased IFN-     production, indicated that Notch  –
  Delta1 pathways were critical regulators of AHR and Th2 
lung allergic responses. The GSI reduced the amount of Notch 
signaling to potentially mimic a Notch1 loss of function phe-
notype. It appears that activated T cells, and CD8  +   T cells 
in particular, pretreated with GSI produce little IFN-     (  20  ). 
We analyzed IFN-     secretion in TCR-activated GSI-T  EFF   cells 
and found production to be signifi  cantly decreased compared 
with similarly treated DMSO-T  EFF   cells (Fig. S5, available at 
http://www.jem.org/cgi/content/full/jem.20072200/DC1). 
After transfer, the majority of IFN-      –  producing cells were lo-
calized to the CD4  +   subset. The data imply that the increase 
in CD4  +  IFN-      +   T cells resulted from the changes in Notch 
signaling ligands expressed on the CD8  +   GSI-T  EFF   cells, i.e., 
up-regulation of Delta1 on GSI-T  EFF   cells interacting with 
Notch receptors on CD4  +   T cells. The total numbers of CD4  +   
T cells in BAL fl  uid (  Fig. 2 C  ) and lung (Fig. S1) were the 
same in recipients of GSI-T  EFF   cells and DMSO-T  EFF   cells. 
However, only after the interactions mediated through Notch 
receptors and Notch ligands on GSI-T  EFF   cells was attenuation 
of CD8-mediated AHR and infl  ammation observed and asso-JEM VOL. 205, May 12, 2008 
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in the presence of 10   μ  g/ml brefeldin A (Sigma-Aldrich). After staining for 
cell surface markers, cells were fi  xed with 4% paraformaldehyde in PBS, 
permeabilized in 0.1% saponin, and stained for intracytoplasmic IFN-     (BD 
Biosciences). The number of IFN-      –  producing CD4  +   or CD8  +   T cells per 
lung was calculated from the percentage of total cells. Stained cells were ana-
lyzed on a FACSCalibur (BD Bioscience) using CELLQuest software. 
  Isolation of GSI-T  EFF   or DMSO-T  EFF   cells from the lungs of sensi-
tized and challenged recipients.     Lung MNCs were isolated from sensi-
tized and challenged CD8      /      mice that received GSI-T  EFF   or DMSO-T  EFF   
cells before secondary challenge. CD8  +   T cells were positively selected using 
magnetic beads coated with anti-CD8 antibody (Miltenyi Biotec). RNA was 
extracted from these isolated CD8  +   GSI-T  EFF   or DMSO-T  EFF   cells and ana-
lyzed by real-time PCR. 
  Real-Time PCR.     Real-time cDNA primers and probes for murine T-bet, 
GATA-3, Delta1, Jagged1, Jagged2, and GAPDH were obtained from Ap-
plied Biosystems. The Delta Delta cycle threshold method was performed 
for relative quantifi  cation of mRNA expression. 
  Statistical analysis.     All results were expressed as the mean   ±   SEM as a 
standard method of presentation for this type of data. The Tukey-Kramer 
test was used for comparisons between multiple groups. Nonparametric 
analysis using the Mann-Whitney   U   test was also used to confi  rm that the 
statistical diff  erences remained signifi  cant even if the underlying distribution 
was uncertain. The p-values for signifi  cance were set to 0.05 for all tests. 
  Online supplemental material.     Fig. S1 shows the number of CD4  +   and 
CD8  +   T cells in the lungs of WT recipients of DMSO-T  EFF   or GSI-T  EFF   
cells. Fig. S2 illustrates cytokine production from the lung cells of WT recip-
ients of DMSO-T  EFF   or GSI-T  EFF   cells. Fig. S3 illustrates cytokine produc-
tion from lung cells in the recipients of Delta1-Fc. Fig. S4 shows expression 
levels of Delta1 on DMSO-T  EFF   or GSI-T  EFF   cells cultured together with 
T  EFF   cells. Fig. S5 shows IFN-     production in GSI-T  EFF   cells. Figs. S1  –  S5 
are available at http://www.jem.org/cgi/content/full/jem.20072200/DC1. 
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